Press release
Angina Pectoris Drugs Market Outlook - Estimated Market Size And Growth Rate 2023-2033
Angina Pectoris Drugs
The Business Research Company's Angina Pectoris Drugs Global Market Report 2023 chronic angina pectoris as the major driver for the Angina Pectoris Drugs market's growth in the forecast period. Chronic angina pectoris is chest pain or discomfort caused by reduced blood flow to the heart muscle. Angina pectoris drugs are vital in treating chronic angina. They can provide several benefits to those suffering from this illness, including coronary heart disease, cardiovascular disease, high blood pressure, and being overweight or obese.
the global angina pectoris drugs market size is expected to grow from $11.20 billion in 2022 to $11.82 billion in 2023 at a compound annual growth rate (CAGR) of 5.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The angina pectoris drugs market size is expected to reach $14.50 billion in 2027 at a CAGR of 5.2%.
Download Free Sample Of Angina Pectoris Drugs Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=10797&type=smp
Major competitors in the Angina Pectoris Drugs market are Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca Plc, Amgen Inc., Gilead Sciences Inc., Bausch Health Companies Inc.
A key trend in the Angina Pectoris Drugs market includes product innovation. Major companies operating in the angina pectoris drug market are adopting new technologies to sustain their position in the market. For instance, in March 2023, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, launched Labetalol Hydrochloride Injection, USP, in a prefilled syringe. The Food and Drug Administration of the United States has authorized this product. In hospitals, 10 mg/2 mL PFS is used to treat severe hypertension and lower blood pressure.
Read More On The Global Angina Pectoris Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report
The Angina Pectoris Drugs market is segmented -
• By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs
• By Indication: Stable Angina, Unstable Angina, Prinzmetal's Angina
• By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations
• By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Angina Pectoris Drugs market.
The Business Research Company's "Global Angina Pectoris Drugs Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Angina Pectoris Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10797
The Table Of Content For The Angina Pectoris Drugs Market Include:
1. Angina Pectoris Drugs Market Executive Summary
2. Angina Pectoris Drugs Market Segments
3. Angina Pectoris Drugs Market Size And Angina Pectoris Drugs Market Growth Rate
4. Key Angina Pectoris Drugs Market Trends
5. Major Angina Pectoris Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Angina Pectoris Drugs Market
26. Top Angina Pectoris Drugs Companies
27. Angina Pectoris Drugs Market Opportunities And Strategies
28. Angina Pectoris Drugs Market, Conclusions And Recommendations
29. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angina Pectoris Drugs Market Outlook - Estimated Market Size And Growth Rate 2023-2033 here
News-ID: 3301026 • Views: …
More Releases from The Business research company
Future of Airborne Sensors Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Airborne Sensors Market by 2025?
In recent times, the market size of airborne sensors has experienced substantial growth. It is estimated to expand from being worth $10.57 billion in 2024 to a worth of $11.26 billion in 2025 with a compound annual…
Small Drone Industry to Achieve $10.09 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Small Drone Market Grow by 2025 in Terms of Size and Growth?
In recent times, there's been a significant increase in the size of the small drone market. The market, currently valued at $5.72 billion in 2024, is expected to increase to $6.43 billion in 2025, indicating a Compound…
Instrument Landing System Market Expansion Outlook: $2.34 Billion in 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Instrument Landing System Market from 2024 to 2025?
In recent years, the market size for the instrument landing system has been expanding significantly. An increase from $1.78 billion in 2024 to $1.89 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of…
Aerospace And Defense Components Market Size Forecast: $103.51 Billion by 2029 | …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Aerospace And Defense Components Market by 2025?
The market size for aerospace and defense components has seen a swift increase in past years. The market will expand from $65.1 billion in 2024 to $71.97 billion in 2025, with a compound annual growth…
More Releases for Angina
Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pecto …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Angina Pectoris Drugs Market Size By 2025?
The market size for angina pectoris drugs has experienced consistent growth in the past few years. The market is projected to expand from $12.32 billion in 2024 to $12.88 billion in 2025, representing a compound annual growth rate…
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina…
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a…
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the built…
Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview
The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow to…
